DMAC

DMAC Retained Earnings

-$192.95MQuarterly · USD

Period ending:

DMAC FY Retained EarningsUSD
DMAC FY Retained Earnings2004-12-31: -$1.97M2005-12-31: -$2.25M2006-12-31: -$3.02M2007-12-31: -$5.89M2008-12-31: -$6.64M2009-12-31: -$10.16M2010-12-31: -$14.90M2011-12-31: -$21.19M2012-12-31: -$31.80M2013-12-31: -$37.12M2014-12-31: -$38.86M2015-12-31: -$33.95M2016-12-31: -$46.71M2017-12-31: -$40.23M2018-12-31: -$45.97M2019-12-31: -$56.62M2020-12-31: -$68.91M2021-12-31: -$82.50M2022-12-31: -$96.18M2023-12-31: -$115.56M2024-12-31: -$140.00M2025-12-31: -$172.77M$0.00-$172.77M
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DMAC retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Diamedica Therapeutics Inc Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
-172,768,000
-140,002,000
-115,558,000
-96,177,000
-82,501,000
-68,909,000
-56,617,000
-45,968,000
-40,234,000
-46,707,308
-33,954,302
-38,864,482
-37,119,287
-31,796,924
-21,187,947
-14,901,080
-10,158,054
-6,644,517
-5,887,735
-3,019,698
-2,249,786
-1,970,078

Compare retained earnings

All DMAC financial metrics · DMAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.